The Influence of Body Mass Index on Treatment Response and Survival in HER2-Positive Breast Cancer Patients
In our cohort, BMI was not found to be a significant predictor of mortality in patients with HER2-positive breast cancer. In multivariate analysis, White race was associated with improved mortality outcomes. More research is needed to eliminate potential disparities in screening and treating cancer.
Institutions
- University of Kansas Medical Center (US)
- University of Arkansas at Fayetteville (US)
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- Cancer Investigation
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1080/07357907.2026.2647336
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00